DEC 23, 2018 11:22 PM PST

Preventive Drug Decreases Cases of Leprosy in Morocco

WRITTEN BY: Nouran Amin

Leprosy, also known as Hansen disease, is a disabling chronic and infectious disease that affects the skin and the peripheral nerves. It has a huge effect on public health of communities and nations as a whole. Since 1981, the introduction of antibacterial multidrug therapy has significantly decreased cases of leprosy on a worldwide scale. However, some countries like Morocco continue to have transmission of leprosy until the implementation of a new program.

Learn more about leprosy:

Now, cases of leprosy has declined in Morocco by more than 16 percent since 2012. This decline is due to the introduction of program involving a preventative drug according to a report published in PLOS Neglected Tropical Diseases. The drug involves a single dose of rifampicin and was introduced through the Single Dose Rifampicin Chemoprophylaxis (SDRC) program with the goal of decreasing the spread of leprosy through household contacts.

The leprosy cases were analyzed each year between 2000 and 2017 with data involving age, gender, origin, region, and grade of disability of leprosy patients. Results show that between 2000 and 2012, before the SDRC program, the leprosy cases was -4.68% per year. Now, between 2012 and 2017--after implementing SDRC the annual percent change per year was -16.83%.

Outpatients department. Kenitra Hospital.

Credit: Mary Gillham Archive Project, Flickr, CC BY 2.0, 2017 via MedicalXpress

"This time series can be of interest for the medical community as the authors analyze the trends in leprosy in the last 17 years and try to generate a hypothesis about any relationship with chemoprophylaxis implementation," the researchers say.

Source: MedicalXpress

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Potential Targeted Treatment for Crohn Disease
Emerging as a global disease with rates increasing the past 5 decades, Crohn’s disease (CD) is the chronic inflammation of the intestinal tract. Now,...
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Anti-Venomous Plant Compound
According to a study published in PLOS Neglected Tropical Diseases, researchers at the Institute Butantan, São Paulo, Brazil, have discovered a flav...
NOV 10, 2018
Genetics & Genomics
NOV 10, 2018
Scientists Engineer a Better Way to Direct Evolution
Directed evolution is a Nobel-prize winning technique that has now been simplified and accelerated....
DEC 23, 2018
Drug Discovery
DEC 23, 2018
Super-Drug for Pediatric Leukemia?
In a final study published in Genes & Development, researchers at Northwestern University School of Medicine concluded their discoveries on two success...
JAN 07, 2019
Cell & Molecular Biology
JAN 07, 2019
Researchers Develop an Experimental Therapy for Triple-negative Breast Cancer
Between 12 and 17% of all breast cancer cases are triple-negative, a highly aggressive type with few therapeutic options....
JAN 15, 2019
Immunology
JAN 15, 2019
A Possible Key to Severe Flu
By studying the impact that NPY and its receptor Y1R have on influenza in mice, the research group has now discovered that NPY produced in lung phagocytes can aggravate influenza....
Loading Comments...